OTUD7A
OTU domain-containing protein 7A
Also known as: C15orf16, CEZANNE2, OTU7A_HUMAN, OTUD7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TE49
- Gene
- OTUD7A
- Ensembl
- ENSG00000169918
- Chromosome
- 15
- Canonical length
- 926 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoli,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a deubiquitinizing enzyme and possible tumor suppressor. The encoded protein acts on TNF receptor associated factor 6 (TRAF6) to control nuclear factor kappa B expression. However, this gene is downregulated by SNAIL1 in hepatocellular carcinoma cells, contributing to their progression and malignancy. [provided by RefSeq, Aug 2016]
Canonical amino-acid sequenceUniProt
926 residues, UniProt reviewed canonical sequence.
>Q8TE49|OTUD7A
1 MVSSVLPNPT SAECWAALLH DPMTLDMDAV LSDFVRSTGA EPGLARDLLE GKNWDLTAAL
61 SDYEQLRQVH TANLPHVFNE GRGPKQPERE PQPGHKVERP CLQRQDDIAQ EKRLSRGISH
121 ASSAIVSLAR SHVASECNNE QFPLEMPIYT FQLPDLSVYS EDFRSFIERD LIEQATMVAL
181 EQAGRLNWWS TVCTSCKRLL PLATTGDGNC LLHAASLGMW GFHDRDLVLR KALYTMMRTG
241 AEREALKRRW RWQQTQQNKE EEWEREWTEL LKLASSEPRT HFSKNGGTGG GVDNSEDPVY
301 ESLEEFHVFV LAHILRRPIV VVADTMLRDS GGEAFAPIPF GGIYLPLEVP PNRCHCSPLV
361 LAYDQAHFSA LVSMEQRDQQ REQAVIPLTD SEHKLLPLHF AVDPGKDWEW GKDDNDNARL
421 AHLILSLEAK LNLLHSYMNV TWIRIPSETR APLAQPESPT ASAGEDVQSL ADSLDSDRDS
481 VCSNSNSNNG KNGKDKEKEK QRKEKDKTRA DSVANKLGSF SKTLGIKLKK NMGGLGGLVH
541 GKMGRANSAN GKNGDSAERG KEKKAKSRKG SKEESGASAS TSPSEKTTPS PTDKAAGASP
601 AEKGGGPRGD AWKYSTDVKL SLNILRAAMQ GERKFIFAGL LLTSHRHQFH EEMIGYYLTS
661 AQERFSAEQE QRRRDAATAA AAAAAAAAAT AKRPPRRPET EGVPVPERAS PGPPTQLVLK
721 LKERPSPGPA AGRAARAAAG GTASPGGGAR RASASGPVPG RSPPAPARQS VIHVQASGAR
781 DEACAPAVGA LRPCATYPQQ NRSLSSQSYS PARAAALRTV NTVESLARAV PGALPGAAGT
841 AGAAEHKSQT YTNGFGALRD GLEFADADAP TARSNGECGR GGPGPVQRRC QRENCAFYGR
901 AETEHYCSYC YREELRRRRE ARGARPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OTUD7A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 9.8 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 9.8 nTPM
- spinal cord: 7 nTPM
- cerebral cortex: 6 nTPM
- hippocampal formation: 5.9 nTPM
- midbrain: 5 nTPM
- amygdala: 4.7 nTPM
Single-cell type
- oligodendrocytes: 672 nCPM
- brain excitatory neurons: 384 nCPM
- brain inhibitory neurons: 300 nCPM
- astrocytes: 254 nCPM
- bergmann glia: 229 nCPM
- other brain neurons: 204 nCPM
Immune cell
- gdT-cell: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- white matter: 51 nTPM
- basal ganglia: 29 nTPM
- medulla oblongata: 28 nTPM
- thalamus: 28 nTPM
- cerebral cortex: 27 nTPM
- pons: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OTUD7A.
Disease | AllUniProt
Conditions OTUD7A is implicated in, by any mechanism.
- Neurodevelopmental disorder with hypotonia and seizures (NEDHS) MIM:620790
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 185 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with hypotonia and seizures
- Specific learning disability
- Language disorder
- Epileptic encephalopathy
- Severe global developmental delay
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 2.87
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein deubiquitination
- protein deubiquitination involved in ubiquitin-dependent protein catabolic process
- protein K11-linked deubiquitination
Molecular functions
- cysteine-type deubiquitinase activity
- DNA binding
- K63-linked polyubiquitin modification-dependent protein binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OTUD7A as an antibody target. Whether an autoantibody or antibody against OTUD7A could matter depends on whether native OTUD7A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OTUD7A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OTUD7A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...